Drug cuts COVID risk for nursing home residents -Eli Lilly

  • Oops!
    Something went wrong.
    Please try again later.

A trial of Eli Lilly's antibody drug shows it can reduce the risk of COVID-19 by 80% for nursing home residents, the company said on Thursday, although the need for such disease prevention tools has dwindled as vaccines become available. This report produced by Jillian Kitchener.